来源:Scientia Pharmaceutica 发布时间:2026/9/14 15:16:05
选择字号:
文献清单:药物递送与纳米载体 | MDPI Scientia Pharmaceutica

期刊名:Scientia Pharmaceutica

期刊主页:https://www.mdpi.com/journal/scipharm

药物递送技术与纳米载体是现代药剂学领域的核心研究方向之一,本专题精选发表于Scientia Pharmaceutica期刊的前沿研究成果,欢迎广大读者查阅。

1. Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations

黄酮类化合物在癌症治疗中的应用:克服生物利用度局限的纳米载体策略

https://www.mdpi.com/2218-0532/94/2/51

Paiva, M.J.M.d.; D’Alessandro, W.B.; Damasceno, I.A.d.M.; Panontin, J.F.; Santos, T.T.d.; Herrera, S.D.S.C.; Santos, M.S.; Trevisan, M. Flavonoids in Cancer Therapy: Nanocarrier Strategies to Overcome Bioavailability Limitations. Sci. Pharm. 2026, 94, 51.

2. The Significance of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) in the Treatment of Atopic Dermatitis

固体脂质纳米粒(SLNs)与纳米结构脂质载体(NLCs)在特应性皮炎治疗中的重要功效

https://www.mdpi.com/2218-0532/94/1/19

Lazov, C.; Yoncheva, K.; Slavkova, M. The Significance of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) in the Treatment of Atopic Dermatitis. Sci. Pharm. 2026, 94, 19.

3. Nanotechnology for Metformin Release Systems: Nanostructures, Biopolymer Carriers, and Techniques—A Review

二甲双胍给药系统中的纳米技术:纳米结构、生物聚合物载体及制备工艺—综述

https://www.mdpi.com/2218-0532/94/1/3

Montaño-Grijalva, E.A.; Rodríguez-Félix, F.; Tapia-Hernández, J.A.; Márquez-Ríos, E.; Del-Toro-Sánchez, C.L.; Rodríguez-Félix, D.E.; Nalda-Molina, R.; Carvajal-Millan, E.; Barreras-Urbina, C.G.; López-Peña, I.Y.; et al. Nanotechnology for Metformin Release Systems: Nanostructures, Biopolymer Carriers, and Techniques—A Review. Sci. Pharm. 2026, 94, 3.

4. Development and Optimisation of Docetaxel-Loaded Polymeric Nanoparticles for Oral Chemotherapy in Breast Cancer

治疗乳腺癌的口服化疗药物负载多西他赛聚合物纳米粒的开发与工艺优化

https://www.mdpi.com/2218-0532/93/4/58

Wali, D.; Nanjappa, S.H.; Kumar, A.; Shinde, R. Development and Optimisation of Docetaxel-Loaded Polymeric Nanoparticles for Oral Chemotherapy in Breast Cancer. Sci. Pharm. 2025, 93, 58.

5. Development and Characterization of Bigels for the Topical Delivery of Curcumin

姜黄素局部给药的双相凝胶的开发与表征研究

https://www.mdpi.com/2218-0532/93/3/28

Peréz-Salas, J.L.; Moreno-Jiménez, M.R.; Medina-Torres, L.; Rocha-Guzmán, N.E.; Bernad-Bernad, M.J.; González-Laredo, R.F.; Gallegos-Infante, J.A. Development and Characterization of Bigels for the Topical Delivery of Curcumin. Sci. Pharm. 2025, 93, 28.

6. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

经皮给药评估用微流控扩散系统的流体动力学优化:实验与模拟研究

https://www.mdpi.com/2218-0532/92/2/35

Kocsis, D.; Dhinakaran, S.; Pandey, D.; Laki, A.J.; Laki, M.; Sztankovics, D.; Lengyel, M.; Vrábel, J.; Naszlady, M.B.; Sebestyén, A.; et al. Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study. Sci. Pharm. 2024, 92, 35.

7. Drug Delivery Nano-Platforms for Advanced Cancer Therapy

用于癌症治疗的纳米药物递送平台

https://www.mdpi.com/2218-0532/92/2/28

Naumenko, E.; Guryanov, I.; Gomzikova, M. Drug Delivery Nano-Platforms for Advanced Cancer Therapy. Sci. Pharm. 2024, 92, 28.

Scientia Pharmaceutica 期刊介绍

主编: Prof. Dr. Helmut Viernstein, University of Vienna, Austria

期刊领域涵盖生药学、药剂学、药物化学、药理学、药物分析学、临床药学、制药技术以及药学经济学、药事管理学等。目前已被 ESCI (Web of Science)、Scopus等数据库收录。最新影响因子3.6。

2025 IF 3.6

2025 CiteScore 5.3

Time to First Decision 22.8 days

Acceptance to Publication 3.1 days

 
 
 
特别声明:本文转载仅仅是出于传播信息的需要,并不意味着代表本网站观点或证实其内容的真实性;如其他媒体、网站或个人从本网站转载使用,须保留本网站注明的“来源”,并自负版权等法律责任;作者如果不希望被转载或者联系转载稿费等事宜,请与我们接洽。
 
 打印  发E-mail给: 
    
 
相关新闻 相关论文

图片新闻
研究揭示甲烷部分氧化制合成气驱动因素 科学家揭示火星大气物质运输规律
超导双层镍氧化物薄膜的三维电子结构 改造人体细胞能否重建骨骼
>>更多
 
一周新闻排行
 
编辑部推荐博文